INDIANAPOLIS, Nov. 13, 2023 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. PNT (the “Company” or “POINT”), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced financial results for the third quarter ended September 30, 2023, and provided a business update. “The founding mission of our…Read More
POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights POINT Biopharma Global NASDAQPNT Eli Lilly NYSELLY
